East A gum quarterly report: net profit of 363 million, up 5.13% YoY

On October 29th, Dong'a Gum released its third quarter 2018 report. The report shows that in the first three quarters of 2018, Dong'a Gum achieved operating income of RMB4.384 billion, net profit attributable to shareholders of listed companies was RMB1.225 billion, and net profit attributable to shareholders of listed companies, net of non-recurring profit and loss, was RMB1.104 billion. In the third quarter, Dong'a Gum achieved a net profit of RMB363 million, up 5.13% YoY.
years, Dong'a gum through the "A gum" and "A gum" strategic approach to continue to promote the A gum cultural marketing and value return project, cultivate a tonic customer base. "2018-2025 China's A gum industry development overview and prospects forecast report" pointed out that the consumer goods market after full competition, each market segment will be left 2-5 oligarchs occupy the vast majority of market share, leading companies will occupy the entire market share of 30% to 40%. At the Xipu Conference held on August 13 this year, the 2018 "China Pharmaceutical Brand List Value List" was announced, with Dong'a gum taking the top spot and achieving its fourth consecutive crown since 2015, further consolidating the position of high-end nourishing health brands.
In 2018, the domestic pharmaceutical industry began to fully implement the "two-vote system", this change has indeed caused a certain impact on the domestic pharmaceutical retail industry, Dong A gum at this time, put forward the "building a community of industrial and commercial destiny" development theme, in 2018 officially opened the distribution channels of the reform curtain, promote strategic cooperation with high-quality distributors, streamline small and medium-sized dealers and other initiatives.
outside analysis pointed out that the channel adjustment carried out this year is actually for the development of the next few years to lay the cornerstone, and the trend of the domestic consumer market also affects the future prospects of a group of high-end tonic brands, including East A gum.
for the first time in the semi-annual report of East Aga, the U.S. fund company Oppenhemmer, and the third-quarter report shows that Oppenhemmer further increased its stake in East A gum, the shareholding has reached 4.01 percent, continue to be the fourth largest shareholder. (Xinhuanet)